Gary A Lyons's Net Worth

Gary A Lyons's net worth is estimated to be at least $19,562,976.00 as of 12/23/2024. CoreStreet's estimation of Gary A Lyons's net worth is based on their sale of stock and current holding of stock.

Gary A Lyons is Director at Travere Therapeutics Inc. They have executed at least 23 trades of stock as per SEC Form 4 filings. Their most recent trade was for 40,000 units of TVTX stock on 10/04/2024. Their biggest sale was on 08/13/2024 when they sold 11,570 units of Neurocrine Biosciences Inc stock for $1,740,475.10. They typically trade 2 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $19,562,976.00
Most recent insider trade:
  • Oct. 4, 2024

Gary A Lyons's Insider Trading History

Travere Therapeutics IncTitleAmountPriceTypeTotal Value
Oct. 4, 2024
Director40,000$14.73Sell$589,200.00
Neurocrine Biosciences IncTitleAmountPriceTypeTotal Value
Aug. 13, 2024
Director11,570$150.43Sell$1,740,475.10
July 16, 2024
Director930$150.03Sell$139,527.90
May 14, 2024
Director12,500$135.63Sell$1,695,375.00
Dec. 1, 2023
Director5,000$116.77Sell$583,850.00
Sept. 12, 2023
Director5,000$115.02Sell$575,100.00
Sept. 1, 2023
Director5,000$110.06Sell$550,300.00
Oct. 31, 2022
Director15,000$114.76Sell$1,721,400.00
Oct. 4, 2022
Director5,000$110.54Sell$552,700.00
April 25, 2022
Director15,000$92.76Sell$1,391,400.00
Oct. 7, 2021
Director5,000$105.06Sell$525,300.00
June 10, 2021
Director10,000$100.27Sell$1,002,700.00
Jan. 25, 2021
Director1,600$120.03Sell$192,048.00
Nov. 8, 2019
Director5,000$110.00Sell$550,000.00
Nov. 1, 2019
Director5,000$100.22Sell$501,100.00
July 30, 2019
Director10,000$92.07Sell$920,700.00
Nov. 2, 2018
Director15,000$114.41Sell$1,716,150.00
June 13, 2018
Director15,000$99.24Sell$1,488,600.00
Feb. 15, 2018
Director5,000$84.67Sell$423,350.00
Feb. 5, 2018
Director5,000$83.08Sell$415,400.00
Dec. 1, 2017
Director10,000$72.92Sell$729,200.00
March 24, 2015
Director30,000$41.53Sell$1,245,900.00
Sept. 15, 2014
Director20,000$15.66Sell$313,200.00